Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019

Table 2

Tumor-type distribution of cancer patients complicated with E. coli BSI.

Tumor type	Cases	Composition ratio (%)
Pancreatic cancer	100	14.35
Gastric cancer	64	9.18
Lymphoma	55	7.89
Cholangiocarcinoma	54	7.75
Lung cancer	40	5.74
Breast cancer	36	5.16
Colon cancer	31	4.45
Cervical cancer	28	4.02
Rectal cancer	27	3.87
Liver cancer	27	3.87
Duodenal cancer	26	3.73
Ovarian cancer	26	3.73
Gallbladder cancer	16	2.30
Sarcoma	14	2.01
Bladder cancer	14	2.01
Endometrial cancer	13	1.87
Prostate cancer	12	1.72
Leukemia	12	1.72
Benign tumor	11	1.58
Kidney cancer	8	1.15
Head and neck cancer	7	1.00
Esophageal cancer	7	1.00
Metastatic cancer	5	0.72
High-grade squamous intraepithelial lesion of the cervix	5	0.72
Inflammation	4	0.57
Vulvar cancer	4	0.57
Neuroblastoma	4	0.57
Benign prostatic hyperplasia	4	0.57
Meningioma	4	0.57
Plasmacytoma	4	0.57
Stromal tumor	4	0.57
Penile cancer	3	0.43
Pancreatic neuroendocrine tumor	3	0.43
Serous cystadenoma of the pancreas	3	0.43
Peritoneal cancer	3	0.43
Multiple myeloma	3	0.43
Vaginal cancer	2	0.29
Glioma	2	0.29
Melanoma	2	0.29
Other malignant tumors	10	1.43
Total	697	100.00